Clinical trials data
Verbal Learning in obesity and diabetes trials: 74 registered studies
Every registered obesity and diabetes study on ClinicalTrials.gov that names Verbal Learning in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered obesity and diabetes studies name it in an outcome measure
- 74
- Name it in a primary outcome, 36%
- 27 of 74
Tests named in the same studies
- 1
Trail Making Test40 studies, 16 as a primary outcome
- 2
Verbal Fluency31 studies, 14 as a primary outcome
- 3
Digit Span Test30 studies, 13 as a primary outcome
- 4
Stroop Color-Word Test28 studies, 11 as a primary outcome
- 5
Symbol Coding22 studies, 13 as a primary outcome
- 6
Category Fluency13 studies, 9 as a primary outcome
- 7
Short Story Recall7 studies, 3 as a primary outcome
- 8
Letter-Number Sequencing Task6 studies, 5 as a primary outcome
- 9
Complex Figure Copy and Recall6 studies, 3 as a primary outcome
- 10
Picture Naming Test6 studies, 3 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 1 | 0 |
| 2010 | 1 | 0 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 3 | 2 |
| 2014 | 2 | 0 |
| 2015 | 5 | 0 |
| 2016 | 7 | 2 |
| 2017 | 3 | 0 |
| 2018 | 7 | 2 |
| 2019 | 5 | 2 |
| 2020 | 2 | 0 |
| 2021 | 2 | 1 |
| 2022 | 9 | 5 |
| 2023 | 5 | 4 |
| 2024 | 8 | 3 |
| 2025 | 7 | 3 |
| 2026 | 4 | 1 |
Phases and study sizes
By phase
- Phase 11 studies, 0 as a primary outcome
- Phase 27 studies, 2 as a primary outcome
- Phase 2/31 studies, 1 as a primary outcome
- Phase 34 studies, 2 as a primary outcome
- Phase 41 studies, 0 as a primary outcome
- Not applicable42 studies, 14 as a primary outcome
- Observational18 studies, 8 as a primary outcome
Participants per study
- Not applicable71 median, 38 to 102
- Observational122 median, 65 to 338
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Not applicable | 42 | 71 | 38 to 102 |
| Observational | 18 | 122 | 65 to 338 |
When obesity and diabetes trials measure it
Latest time point of each outcome
- Within a day8 outcomes, 3 as a primary outcome
- Up to 4 weeks5 outcomes, 1 as a primary outcome
- 1 to 3 months15 outcomes, 5 as a primary outcome
- 3 to 6 months19 outcomes, 5 as a primary outcome
- 6 to 12 months8 outcomes, 4 as a primary outcome
- 1 to 2 years4 outcomes, 2 as a primary outcome
- Over 2 years10 outcomes, 4 as a primary outcome
- No duration given5 outcomes, 3 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
69 of the 74 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting16 studies, 7 as a primary outcome
- Not yet recruiting2 studies, 0 as a primary outcome
- Active, not recruiting5 studies, 2 as a primary outcome
- Completed45 studies, 15 as a primary outcome
- Stopped early4 studies, 2 as a primary outcome
- Status unknown2 studies, 1 as a primary outcome
What they test
- Behavioral26 studies, 10 as a primary outcome
- Drug13 studies, 4 as a primary outcome
- Device2 studies, 1 as a primary outcome
- Dietary supplement9 studies, 1 as a primary outcome
- Procedure5 studies, 0 as a primary outcome
- Biological1 studies, 0 as a primary outcome
- Genetic1 studies, 0 as a primary outcome
- Other20 studies, 9 as a primary outcome
- None given9 studies, 5 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States40 studies, 11 as a primary outcome
- Spain7 studies, 3 as a primary outcome
- China5 studies, 3 as a primary outcome
- Canada4 studies, 1 as a primary outcome
- Germany4 studies, 1 as a primary outcome
- Denmark3 studies, 2 as a primary outcome
- Greece2 studies, 1 as a primary outcome
- Netherlands2 studies, 0 as a primary outcome
- United Kingdom2 studies, 0 as a primary outcome
- Australia1 studies, 1 as a primary outcome
- Belgium1 studies, 0 as a primary outcome
- Brazil1 studies, 1 as a primary outcome
16 countries in all. A study with sites in several counts in each; 2 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed obesity and diabetes studies that name Verbal Learning: 24 of 45, 53%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed obesity and diabetes studies that name Verbal Learning | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 8, 18% | 776, 10% |
| Results on ClinicalTrials.gov only | 4, 9% | 1,139, 14% |
| A results paper only | 12, 27% | 1,711, 22% |
| Neither | 21, 47% | 4,327, 54% |
The 74 studies
74 studies match. 27 name Verbal Learning in a primary outcome. Median size 83 participants. Median time to the primary outcome: 6 months.
Loading 74 studies; the filters turn on when they arrive.
2026 is partly planned starts. Not shown: 1 that started before 2000.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 1 | 0 |
| 2010 | 1 | 0 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 3 | 2 |
| 2014 | 2 | 0 |
| 2015 | 5 | 0 |
| 2016 | 7 | 2 |
| 2017 | 3 | 0 |
| 2018 | 7 | 2 |
| 2019 | 5 | 2 |
| 2020 | 2 | 0 |
| 2021 | 2 | 1 |
| 2022 | 9 | 5 |
| 2023 | 5 | 4 |
| 2024 | 8 | 3 |
| 2025 | 7 | 3 |
| 2026 | 4 | 1 |
Library tests named most
Largest condition groups
Phases
Participants
Lead sponsor: industry 3, NIH 2, other 69. Interventional 56, observational 18.
As a primary outcomeSecondary or other outcomeVerbal Learning
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07704229 | Start2026 | PhaseObservational | ConditionsObesity and diabetes | Participants150 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07501377 | Start2026 | PhaseNot applicable | ConditionsObesity and diabetes | Participants120 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07485062 | Start2026 | PhasePhase 4 | ConditionsAging, frailty and exercise, Obesity and diabetes | Participants164 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07420699 | Start2023 | PhaseNot applicable | ConditionsObesity and diabetes | Participants40 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07374705 | Start2026 | PhaseObservational | ConditionsObesity and diabetes | Participants150 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07284316 | Start2025 | PhasePhase 2/3 | ConditionsObesity and diabetes | Participants100 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT07203196 | Start2025 | PhaseNot applicable | ConditionsAging, frailty and exercise, Obesity and diabetes, Sleep and sleep disorders | Participants16 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT07164768 | Start2024 | PhaseObservational | ConditionsObesity and diabetes | Participants400 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07040748 | Start2025 | PhaseNot applicable | ConditionsObesity and diabetes | Participants84 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06912321 | Start2024 | PhaseObservational | ConditionsObesity and diabetes | Participants400 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06869941 | Start2025 | PhaseObservational | ConditionsObesity and diabetes | Participants100 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06867198 | Start2025 | PhaseNot applicable | ConditionsObesity and diabetes, Cardiovascular disease | Participants72 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06857994 | Start2025 | PhaseObservational | ConditionsObesity and diabetes, Cardiovascular disease | Participants101 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06781762 | Start2025 | PhaseObservational | ConditionsCancer, Obesity and diabetes | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06735651 | Start2024 | PhaseNot applicable | ConditionsObesity and diabetes | Participants30 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06735599 | Start2024 | PhaseNot applicable | ConditionsObesity and diabetes, Cardiovascular disease | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06734546 | Start2024 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Obesity and diabetes | Participants75 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06524388 | Start2024 | PhaseNot applicable | ConditionsAging, frailty and exercise, Obesity and diabetes | Participants120 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06496412 | Start2024 | PhaseNot applicable | ConditionsObesity and diabetes | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06243172 | Start2024 | PhaseObservational | ConditionsObesity and diabetes, Sleep and sleep disorders | Participants60 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06069739 | Start2016 | PhaseNot applicable | ConditionsObesity and diabetes | Participants29 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05997316 | Start2023 | PhaseNot applicable | ConditionsMild cognitive impairment, Obesity and diabetes | Participants33 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05880095 | Start2023 | PhaseNot applicable | ConditionsAging, frailty and exercise, Obesity and diabetes | Participants176 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05835999 | Start2023 | PhasePhase 2 | ConditionsAging, frailty and exercise, Obesity and diabetes | Participants106 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05709847 | Start2023 | PhaseNot applicable | ConditionsObesity and diabetes | Participants70 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
Questions, answered from the data
How many obesity and diabetes trials use Verbal Learning?
74 registered obesity and diabetes studies on ClinicalTrials.gov name it in an outcome measure, 27 of them in a primary outcome: 12% of the condition's 627 studies with a cognitive outcome, against 11% of all of them. It is the 3rd most named test in obesity and diabetes trials.
Which tests do obesity and diabetes trials use with Verbal Learning?
The Trail Making Test (40 studies), Verbal Fluency (31 studies) and the Digit Span Test (30 studies).
When do obesity and diabetes trials measure Verbal Learning?
Half of the primary outcomes that name Verbal Learning are measured within 6 months of the start, and the middle half from 12 weeks to 12 months. 24 primary outcomes give a duration.
How many completed obesity and diabetes trials that use Verbal Learning have reported results?
24 of the 45 completed studies that name it, 53%, have reported results: 12 posted them on ClinicalTrials.gov, 20 have a results paper linked to the registry record, and 8 did both. The other 21 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
The census counts Verbal Learning and Grocery Trip Game as one test family, so this page counts their studies together.
Run Verbal Learning in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.